Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-01-11 @ 7:50 PM
Study NCT ID:
NCT04911660
Status:
COMPLETED
Last Update Posted:
2023-05-12
First Post:
2021-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
Sponsor:
Insel Gruppe AG, University Hospital Bern
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020-02679
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None